Archives

by in
Entry Author Date Location
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Cubist Prices $400M Notes Offering 10/20/10 Boston
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body 09/21/10 San Francisco
Stealthy Mercator, Founded by Biogen Idec Veterans, Raises $2M to Attack Cancer 08/11/10 Boston
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market 05/11/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News 03/19/10 Boston
Forma to Discover Lymphoma Drugs in Deal with Leukemia & Lymphoma Society 03/15/10 Boston
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy 02/16/10 Boston
Vertex CEO on Building a Blockbuster, Genzyme Investor on Fixing Up the Firm, Cubist CEO on Pipeline and Patent Challenges, & More Boston-Area Life Sciences News 01/28/10 Boston
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline 01/25/10 Boston
Alnylam Maps Out First Steps in ‘RNA Decade’ 01/11/10 Boston
Aveo Aims for $86M Debut, Exagrid Snags $16M, PatientKeeper Adds $13M, & More Boston-Area Deals News 12/18/09 Boston
Calixa Gets Acquired, Pfēnex signs Merck to Licensing Deal, Local Biotechs Report From Breast Cancer Symposium, & More San Diego Life Sciences News 12/17/09 San Diego
Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News 12/16/09 Boston
Cubist to Acquire Calixa Therapeutics in Deal Worth up to $402.5M 12/14/09 Boston
Forma Therapeutics Snags $25.5M Venture Round, Punctuating Startup’s Breakout Year 12/01/09 Boston
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters 11/10/09 Seattle
Flexion Pulls in $33M, Cubist Teams With Hydra, Charles River Makes Cuts, & More Boston-Area Life Sciences News 10/21/09 Boston
Hydra, Cubist Seek New Pain Drugs 10/19/09 Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten 10/08/09 Boston
Alnylam Takes Moment to Pause on Cutting Edge, Mull Options on RSV Game Plan 08/11/09 Boston
aTyr Pharma Raises $12 Million in Venture Funding 07/28/09 San Diego
Cerulean Pharma Grabs $10M for Nanoparticle Drugs 07/28/09 Boston
Dr. Sue Skates Where the Puck is Heading in Life Sciences–Waltham 05/19/09 Boston
How to Raise $50M in a Recession: Highlights from the Xconomy Life Sciences Forum 05/01/09 Boston
Biogen and Icahn Duel Again, Marinus Gets $20M, Vigilance Urged on Patent Reform, & More Boston-Area Life Sciences News 04/15/09 Boston
Fetzer New CEO of Cerulean Pharma 04/08/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter 03/17/09 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.